Figure 1From: Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trialThe cumulative percentage of increase in Larsen score from baseline to 11 years in patients initially randomized to receive a combination (FIN-RACo) of disease-modifying antirheumatic drugs (DMARDs) or a single DMARD (SINGLE).Back to article page